2009
DOI: 10.1111/j.1742-7843.2009.00402.x
|View full text |Cite
|
Sign up to set email alerts
|

5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Increases Myocardial Glucose Uptake during Reperfusion and Induces Late Pre-conditioning: Potential Role of AMP-Activated Protein Kinase

Abstract: Late pre-conditioning protects against myocardial ischaemic-reperfusion injury. AMP-activated protein kinase (AMPK) is activated by exercise and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Early pre-conditioning involves AMPK activation and increased myocardial glucose uptake. The aim of the present study was to determine whether AICAR activates myocardial AMPK and induces late pre-conditioning and whether myocardial glucose uptake during reperfusion was modulated. Twenty-four hours after A… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 47 publications
0
13
0
Order By: Relevance
“…We found that infarct size in aged animals was relatively small (∼12%) (as previously reported [2]) and AICAR treatment did not alter infarct size or area at risk (Supplemental Figure 4B). Despite the fact that ischemia itself markedly activates AMPK, it has been demonstrated in isolated reperfused hearts that AICAR reduces infarct size in young animals [40-42]. In this study the role of AICAR does not appear to relate to myocardial infarction size; moreover, there is no apparent AICAR effect seen in the first week of infarction (AICAR treatment ceased 5 days post-MI).…”
Section: Discussionmentioning
confidence: 57%
“…We found that infarct size in aged animals was relatively small (∼12%) (as previously reported [2]) and AICAR treatment did not alter infarct size or area at risk (Supplemental Figure 4B). Despite the fact that ischemia itself markedly activates AMPK, it has been demonstrated in isolated reperfused hearts that AICAR reduces infarct size in young animals [40-42]. In this study the role of AICAR does not appear to relate to myocardial infarction size; moreover, there is no apparent AICAR effect seen in the first week of infarction (AICAR treatment ceased 5 days post-MI).…”
Section: Discussionmentioning
confidence: 57%
“…AMPK is believed to be quiescent in the heart when energy supply-demand is in balance, but is activated during changing metabolic conditions (such as exercise or ischemia; reviewed in 4 and 66). Pharmacological activation of AMPK has been shown to reduce infarct size to a similar degree as exercise preconditioning (69). Cardiac AMPK is activated following treadmill running, with the AMPK␣-2 isoform appearing to be the most responsive (30,69,95).…”
Section: How Much Exercise Is Needed To Protect the Heart?mentioning
confidence: 99%
“…Pharmacological activation of AMPK has been shown to reduce infarct size to a similar degree as exercise preconditioning (69). Cardiac AMPK is activated following treadmill running, with the AMPK␣-2 isoform appearing to be the most responsive (30,69,95). Relating to the cardioprotective mechanism of action, AMPK activation is postulated to stimulate glucose/fat metabolism in the heart during metabolic stress (4,66), and may promote translocation of cardiac ATP-sensitive potassium channel subunits (123; described in more detail below).…”
Section: How Much Exercise Is Needed To Protect the Heart?mentioning
confidence: 99%
“…and AICAR (0.7 mg/g i.p.) 12 h before IRI) [11]. ; (v) melatonin + rapamycin group (treated with melatonin (20 mg/kg i.p.)…”
Section: Methodsmentioning
confidence: 99%